MOTS Motus GI Holdings

Motus GI Scheduled to Participate in the Piper Sandler 32nd Annual Healthcare Conference

Motus GI Scheduled to Participate in the Piper Sandler 32nd Annual Healthcare Conference

FORT LAUDERDALE, Fla., Nov. 25, 2020 (GLOBE NEWSWIRE) -- , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that its management team is scheduled to participate in the Piper Sandler 32nd Annual Healthcare Conference, which is scheduled to take place virtually from December 1-3, 2020.

Tim Moran, Chief Executive Officer of Motus GI, will participate in a fireside chat that will be available via webcast on the Piper Sandler conference site () from November 25th to December 3rd, and on the Events page on the Company’s website, . An archive of the webcast will continue to be available on the Company’s website for 90 days.

In addition, the Motus GI management team will be participating in 1x1 meetings on December 2, 2020, meetings may be requested exclusively via Piper Sandler.

About Motus GI

Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions.

For more information, visit and connect with the Company on , and .

Investor Contact:

Bob Yedid

LifeSci Advisors

(646) 597-6989



EN
25/11/2020

Underlying

MOTSMotus GI Holdings

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Motus GI Holdings

 PRESS RELEASE
Free
MOTS Motus GI Holdin...

Motus GI Reports First Quarter 2024 Financial Results and Provides Cor...

Motus GI Reports First Quarter 2024 Financial Results and Provides Corporate Update Successfully ramped up limited U.S. commercial launch of the Pure-Vu® EVS Gastro and Gen 4 Colon system; Doubled the number of active Pure-Vu System customers ordering disposable sleeves with 100% of onboarded customers using Pure-Vu independently Appointed well-known investment bank to identify and evaluate strategic alternatives aimed at accelerating commercialization of the Pure-Vu System and maximizing stockholder value FORT LAUDERDALE, Fla., May 14, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, In...

May 14, 2024 1 EN
 PRESS RELEASE
Free
MOTS Motus GI Holdin...

Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results a...

Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update Initiated limited U.S. commercial launch of the Pure-Vu® EVS Gastro and Gen 4 Colon system, including successful UGI procedures at several leading hospital systemsThe Company is engaged in the process to seek strategic partnerships aimed at accelerating commercialization of the Pure-Vu System and maximizing stockholder valueRecent exercise of certain outstanding warrants provided infusion of $2.7M in gross proceeds to the Company, which extended its cash runway into the fourth quarter of 2024 ...

March 18, 2024 1 EN
 PRESS RELEASE
Free
MOTS Motus GI Holdin...

Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Millio...

Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds FORT LAUDERDALE, Fla., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (Nasdaq: MOTS, or “Motus” or “the Company”), a medical technology company focused on improving endoscopic outcomes and experiences, today announced that it has entered into a definitive agreement for the immediate exercise of an outstanding Series B common stock purchase warrant held by an institutional investor to purchase an aggregate of 2,933,334 shares of the Company’s common stock for gross proceeds to the Company of ...

February 22, 2024 1 EN
 PRESS RELEASE
Free
MOTS Motus GI Holdin...

Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by ...

Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract FORT LAUDERDALE, Fla., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (“the “Company”) (NASDAQ: MOTS), a medical technology company focused on improving endoscopic outcomes and experiences, today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new patent (patent # 11904085) titled, “Colon Cleaning System with Automatic Self-Purging Feature.” “We are pleased to announce further strengthening our IP po...

February 21, 2024 1 EN
 PRESS RELEASE
Free
MOTS Motus GI Holdin...

Motus GI Holdings, Inc. Announces Adjournment of the February 16, 2024...

Motus GI Holdings, Inc. Announces Adjournment of the February 16, 2024 Special Meeting of Stockholders FORT LAUDERDALE, Fla., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (“the Company”) (NASDAQ: MOTS), today announced that its special meeting of stockholders held on February 16, 2024 (the “Special Meeting”) was convened and then adjourned, without conducting any business, in order to provide stockholders additional time within which to vote on the proposal described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission (the “SEC”) on J...

February 16, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch